Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000673399 | SCV000798597 | likely pathogenic | Autosomal recessive Alport syndrome | 2018-03-15 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002477507 | SCV002789649 | pathogenic | Autosomal recessive Alport syndrome; Benign familial hematuria | 2021-08-27 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002532147 | SCV003525201 | pathogenic | not provided | 2022-12-29 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 557279). This premature translational stop signal has been observed in individual(s) with clinical features of Alport syndrome (PMID: 25596306, 31312213). This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Tyr1533*) in the COL4A4 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in COL4A4 are known to be pathogenic (PMID: 21196518, 24854265, 25307543). |
Renal Department, |
RCV000850092 | SCV000992256 | pathogenic | Autosomal dominant Alport syndrome | 2018-12-01 | no assertion criteria provided | research |